Covaxin: WHO to decide on grant of EUL today

G Naga Sridhar Hyderabad | Updated on October 05, 2021

SAGE will review Covaxin’s data in a meeting held in Geneva

The World Heath Organisation will take a decision on grant of Emergency Use Licence (EUL) to Bharat Biotech's Covid vaccine, Covaxin, on Tuesday.

The Strategic Advisory Group of Experts on Immunisation (SAGE) of WHO will review Covaxin’ data on October 5 in a meeting to be held in Geneva.

Hyderabad-based Bharat Biotech will make a presentation of clinical data on Covaxin's phase 1, 2, 3 and post marketing studies on safety, immunogenlclty, efflcacy and effectiveness, as per the agenda of the meeting.

It will also submit the details ongoing and planned studies on safety and effectiveness.

In addition, it will update the expert group on global, regional and country level plans for vaccine safety monitoring.

SAGE will also examine the evidence on the need for additional Covid-19 vaccine doses for immunosuppressed individuals.

Published on October 05, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.

You May Also Like